Cargando…

Non‐invasive assessment of temporal changes in myocardial microvascular function in persons with type 2 diabetes and healthy controls

BACKGROUND: Cardiac Rubidium‐82 ((82)Rb) positron emission tomography/computed tomography (PET/CT) provides a measure of the myocardial blood flow and the myocardial flow reserve, which reflects the function of both large epicardial arteries and the myocardial microcirculation. Knowledge on changes...

Descripción completa

Detalles Bibliográficos
Autores principales: Rasmussen, Ida K. B., Hasbak, Philip, von Scholten, Bernt J., Laursen, Jens C., Zobel, Emilie H., Jorge Diaz, Lars, Holmvang, Lene, Ripa, Rasmus S., Rossing, Peter, Kjaer, Andreas, Hansen, Tine W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248340/
https://www.ncbi.nlm.nih.gov/pubmed/33434331
http://dx.doi.org/10.1111/dme.14517
_version_ 1783716702052155392
author Rasmussen, Ida K. B.
Hasbak, Philip
von Scholten, Bernt J.
Laursen, Jens C.
Zobel, Emilie H.
Jorge Diaz, Lars
Holmvang, Lene
Ripa, Rasmus S.
Rossing, Peter
Kjaer, Andreas
Hansen, Tine W.
author_facet Rasmussen, Ida K. B.
Hasbak, Philip
von Scholten, Bernt J.
Laursen, Jens C.
Zobel, Emilie H.
Jorge Diaz, Lars
Holmvang, Lene
Ripa, Rasmus S.
Rossing, Peter
Kjaer, Andreas
Hansen, Tine W.
author_sort Rasmussen, Ida K. B.
collection PubMed
description BACKGROUND: Cardiac Rubidium‐82 ((82)Rb) positron emission tomography/computed tomography (PET/CT) provides a measure of the myocardial blood flow and the myocardial flow reserve, which reflects the function of both large epicardial arteries and the myocardial microcirculation. Knowledge on changes in the myocardial microvascular function over time is lacking. METHODS: In this cohort study, we recruited 60 persons with type 2 diabetes and 30 non‐diabetic controls, in 2013; all free of overt cardiovascular disease. All underwent a cardiac (82)Rb PET/CT scan. In 2019, all survivors (n = 82) were invited for a repeated cardiac (82)Rb PET/CT scan using the same protocol, and 29 with type 2 diabetes and 19 controls participated. RESULTS: Median duration between visits was 6.2 years (IQR: 6.1–6.3). In the total cohort, the mean age was 66.4 years (SD: 9.3) and 33% were females. The myocardial flow reserve was lower in persons with type 2 diabetes compared to controls (p = 0.002) but there was no temporal change in the myocardial flow reserve in participants with type 2 diabetes: mean change: −0.22 (95% CI: −0.47 to 0.02) nor in controls: −0.12 (−0.49 to 0.25) or when comparing type 2 diabetes to controls: mean difference: −0.10 (95% CI: −0.52 to 0.31). The temporal reduction in stress‐induced myocardial blood flow did not differ within the groups but was more pronounced in type 2 diabetes compared to controls: mean difference: −0.30 (95% CI: −0.55 to −0.04). CONCLUSION: The myocardial microvascular function was impaired in persons with type 2 diabetes compared to controls but did not change significantly in either of the groups when evaluated over 6 years.
format Online
Article
Text
id pubmed-8248340
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82483402021-07-06 Non‐invasive assessment of temporal changes in myocardial microvascular function in persons with type 2 diabetes and healthy controls Rasmussen, Ida K. B. Hasbak, Philip von Scholten, Bernt J. Laursen, Jens C. Zobel, Emilie H. Jorge Diaz, Lars Holmvang, Lene Ripa, Rasmus S. Rossing, Peter Kjaer, Andreas Hansen, Tine W. Diabet Med Research: Complications BACKGROUND: Cardiac Rubidium‐82 ((82)Rb) positron emission tomography/computed tomography (PET/CT) provides a measure of the myocardial blood flow and the myocardial flow reserve, which reflects the function of both large epicardial arteries and the myocardial microcirculation. Knowledge on changes in the myocardial microvascular function over time is lacking. METHODS: In this cohort study, we recruited 60 persons with type 2 diabetes and 30 non‐diabetic controls, in 2013; all free of overt cardiovascular disease. All underwent a cardiac (82)Rb PET/CT scan. In 2019, all survivors (n = 82) were invited for a repeated cardiac (82)Rb PET/CT scan using the same protocol, and 29 with type 2 diabetes and 19 controls participated. RESULTS: Median duration between visits was 6.2 years (IQR: 6.1–6.3). In the total cohort, the mean age was 66.4 years (SD: 9.3) and 33% were females. The myocardial flow reserve was lower in persons with type 2 diabetes compared to controls (p = 0.002) but there was no temporal change in the myocardial flow reserve in participants with type 2 diabetes: mean change: −0.22 (95% CI: −0.47 to 0.02) nor in controls: −0.12 (−0.49 to 0.25) or when comparing type 2 diabetes to controls: mean difference: −0.10 (95% CI: −0.52 to 0.31). The temporal reduction in stress‐induced myocardial blood flow did not differ within the groups but was more pronounced in type 2 diabetes compared to controls: mean difference: −0.30 (95% CI: −0.55 to −0.04). CONCLUSION: The myocardial microvascular function was impaired in persons with type 2 diabetes compared to controls but did not change significantly in either of the groups when evaluated over 6 years. John Wiley and Sons Inc. 2021-01-25 2021-06 /pmc/articles/PMC8248340/ /pubmed/33434331 http://dx.doi.org/10.1111/dme.14517 Text en © 2021 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research: Complications
Rasmussen, Ida K. B.
Hasbak, Philip
von Scholten, Bernt J.
Laursen, Jens C.
Zobel, Emilie H.
Jorge Diaz, Lars
Holmvang, Lene
Ripa, Rasmus S.
Rossing, Peter
Kjaer, Andreas
Hansen, Tine W.
Non‐invasive assessment of temporal changes in myocardial microvascular function in persons with type 2 diabetes and healthy controls
title Non‐invasive assessment of temporal changes in myocardial microvascular function in persons with type 2 diabetes and healthy controls
title_full Non‐invasive assessment of temporal changes in myocardial microvascular function in persons with type 2 diabetes and healthy controls
title_fullStr Non‐invasive assessment of temporal changes in myocardial microvascular function in persons with type 2 diabetes and healthy controls
title_full_unstemmed Non‐invasive assessment of temporal changes in myocardial microvascular function in persons with type 2 diabetes and healthy controls
title_short Non‐invasive assessment of temporal changes in myocardial microvascular function in persons with type 2 diabetes and healthy controls
title_sort non‐invasive assessment of temporal changes in myocardial microvascular function in persons with type 2 diabetes and healthy controls
topic Research: Complications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248340/
https://www.ncbi.nlm.nih.gov/pubmed/33434331
http://dx.doi.org/10.1111/dme.14517
work_keys_str_mv AT rasmussenidakb noninvasiveassessmentoftemporalchangesinmyocardialmicrovascularfunctioninpersonswithtype2diabetesandhealthycontrols
AT hasbakphilip noninvasiveassessmentoftemporalchangesinmyocardialmicrovascularfunctioninpersonswithtype2diabetesandhealthycontrols
AT vonscholtenberntj noninvasiveassessmentoftemporalchangesinmyocardialmicrovascularfunctioninpersonswithtype2diabetesandhealthycontrols
AT laursenjensc noninvasiveassessmentoftemporalchangesinmyocardialmicrovascularfunctioninpersonswithtype2diabetesandhealthycontrols
AT zobelemilieh noninvasiveassessmentoftemporalchangesinmyocardialmicrovascularfunctioninpersonswithtype2diabetesandhealthycontrols
AT jorgediazlars noninvasiveassessmentoftemporalchangesinmyocardialmicrovascularfunctioninpersonswithtype2diabetesandhealthycontrols
AT holmvanglene noninvasiveassessmentoftemporalchangesinmyocardialmicrovascularfunctioninpersonswithtype2diabetesandhealthycontrols
AT riparasmuss noninvasiveassessmentoftemporalchangesinmyocardialmicrovascularfunctioninpersonswithtype2diabetesandhealthycontrols
AT rossingpeter noninvasiveassessmentoftemporalchangesinmyocardialmicrovascularfunctioninpersonswithtype2diabetesandhealthycontrols
AT kjaerandreas noninvasiveassessmentoftemporalchangesinmyocardialmicrovascularfunctioninpersonswithtype2diabetesandhealthycontrols
AT hansentinew noninvasiveassessmentoftemporalchangesinmyocardialmicrovascularfunctioninpersonswithtype2diabetesandhealthycontrols